Helicobacter pylori and cancer in Uganda
Author Information
Author(s): Newton Robert, Ziegler John L, Casabonne Delphine, Carpenter Lucy, Gold Benjamin D, Owens Marilyn, Beral Valerie, Mbidde Edward, Parkin D Maxwell, Wabinga Henry, Mbulaiteye Sam, Jaffe Harold, the Uganda Kaposi's Sarcoma Study Group
Primary Institution: University of York
Hypothesis
What is the prevalence and role of Helicobacter pylori antibodies in relation to cancer risk among adults in Uganda?
Conclusion
The study found that 87% of patients had antibodies against H. pylori, with lower prevalence in older adults and those who are HIV positive.
Supporting Evidence
- The prevalence of H. pylori antibodies was 87% among all patients, excluding those with stomach cancer.
- Antibody prevalence declined with increasing age and was lower among HIV positive individuals.
- Among stomach cancer patients, 86% had anti-H. pylori antibodies.
Takeaway
Most people in this study had a germ called H. pylori in their blood, which can be linked to stomach problems, but older people and those with HIV had it less often.
Methodology
Patients were recruited from hospitals, interviewed about demographics and lifestyle, and tested for H. pylori antibodies.
Potential Biases
Potential biases may arise from the reliance on self-reported data and the limited demographic diversity of the sample.
Limitations
The study had a small number of stomach cancer cases, which may limit the ability to detect associations.
Participant Demographics
Participants included adults aged 15 and older with various cancer types and benign tumors, primarily from Kampala, Uganda.
Statistical Information
P-Value
0.02
Confidence Interval
0.2–2.9
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website